Genital swelling
(UMLS:C1963789)
- UMLS ID:
- C1963789
- MeSH ID:
- N/A
Synonym(s)
1.
Genital swelling
Associated Drug(s)
| Name | Number of Reports | Reference(s) | Data Source | |
|---|---|---|---|---|
| 1 | Sildenafil Citrate | FAERS: 23 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 2 | Miconazole | FAERS: 6 | OFFSIDES US FAERS | |
| 3 | Norgestrel | FAERS: 6 | US FAERS | |
| 4 | Atorvastatin | FAERS: 5 | US FAERS | |
| 5 | 2-(3-(4-ethoxybenzyl)-4-chlorophenyl)-6-hydroxymethyltetrahydro-2H-pyran-3,4,5-triol | FAERS: 4 | US FAERS | |
| 6 | Citalopram | FAERS: 4 | OFFSIDES US FAERS | |
| 7 | Clarithromycin | FAERS: 4 | US FAERS | |
| 8 | Lenalidomide | FAERS: 4 | US FAERS | |
| 9 | MDV 3100 | FAERS: 4 | US FAERS | |
| 10 | Estrogens, Conjugated (USP) | FAERS: 3 | US FAERS | |
| 11 | Thalidomide | FAERS: 3 | US FAERS | |
| 12 | Triamcinolone Acetonide | FAERS: 3 | US FAERS | |
| 13 | Canagliflozin | FAERS: 2 | US FAERS | |
| 14 | Fluconazole | FAERS: 2 | US FAERS | |
| 15 | Moxifloxacin | FAERS: 2 | US FAERS | |
| 16 | Pregabalin | FAERS: 2 | US FAERS | |
| 17 | Rifaximin | FAERS: 2 | US FAERS | |
| 18 | Sitagliptin Phosphate | FAERS: 2 | US FAERS | |
| 19 | Tadalafil | FAERS: 2 | US FAERS | |
| 20 | atovaquone, proguanil drug combination | FAERS: 2 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 21 | levocetirizine | FAERS: 2 | US FAERS | |
| 22 | tioconazole | FAERS: 2 | OFFSIDES US FAERS | |
| 23 | venetoclax | FAERS: 2 | US FAERS | |
| 24 | Alprostadil | FAERS: 1 | US FAERS | |
| 25 | Azithromycin | FAERS: 1 | US FAERS | |
| 26 | Baclofen | FAERS: 1 | US FAERS | |
| 27 | Bupropion | FAERS: 1 | US FAERS | |
| 28 | Cefdinir | FAERS: 1 | US FAERS | |
| 29 | Clindamycin | FAERS: 1 | US FAERS | |
| 30 | Clobetasol | FAERS: 1 | US FAERS | |
| 31 | Clobetasol | FAERS: 1 | US FAERS | |
| 32 | Cytarabine | FAERS: 1 | US FAERS | |
| 33 | Dinoprostone | FAERS: 1 | US FAERS | |
| 34 | Diovan Hct | FAERS: 1 | US FAERS | |
| 35 | Diphenhydramine | FAERS: 1 | US FAERS | |
| 36 | Doxycycline | FAERS: 1 | US FAERS | |
| 37 | Estradiol | FAERS: 1 | US FAERS | |
| 38 | Ezetimibe | FAERS: 1 | US FAERS | |
| 39 | Finasteride | FAERS: 1 | US FAERS | |
| 40 | Fulvestrant | FAERS: 1 | OFFSIDES US FAERS | |
| 41 | Furosemide | FAERS: 1 | US FAERS | |
| 42 | Glatiramer Acetate | FAERS: 1 | US FAERS | |
| 43 | Imiquimod | FAERS: 1 | US FAERS | |
| 44 | Insulin degludec | FAERS: 1 | US FAERS | |
| 45 | Isotretinoin | FAERS: 1 | US FAERS | |
| 46 | Junel 1/20 | FAERS: 1 | US FAERS | |
| 47 | Ketoconazole | FAERS: 1 | US FAERS | |
| 48 | Kombiglyze XR | FAERS: 1 | US FAERS | |
| 49 | LCZ 696 | FAERS: 1 | US FAERS | |
| 50 | Lamotrigine | FAERS: 1 | US FAERS | |
| 51 | Leuprolide | FAERS: 1 | US FAERS | |
| 52 | Methylphenidate | FAERS: 1 | US FAERS | |
| 53 | Methyltestosterone | FAERS: 1 | US FAERS | |
| 54 | Miconazole | FAERS: 1 | US FAERS | |
| 55 | Mitomycin | FAERS: 1 | US FAERS | |
| 56 | Naltrexone | FAERS: 1 | US FAERS | |
| 57 | Naproxen | FAERS: 1 | US FAERS | |
| 58 | Nexium 24hr | FAERS: 1 | US FAERS | |
| 59 | Omeprazole | FAERS: 1 | US FAERS | |
| 60 | Tamsulosin | FAERS: 1 | US FAERS | |
| 61 | Tiotropium Bromide | FAERS: 1 | US FAERS | |
| 62 | Venlafaxine Hydrochloride | FAERS: 1 | US FAERS | |
| 63 | empagliflozin | FAERS: 1 | US FAERS | |
| 64 | methylnaltrexone | FAERS: 1 | US FAERS | |
| 65 | mirabegron | FAERS: 1 | US FAERS | |
| 66 | pazopanib | FAERS: 1 | US FAERS | |
| 67 | reviparin | FAERS: 1 | US FAERS | |
| 68 | teriflunomide | FAERS: 1 | US FAERS | |
| 69 | tofacitinib | FAERS: 1 | US FAERS | |
| 70 | Dasatinib | SIDER | ||
| 71 | Morphine | SIDER | ||
| 72 | Nortriptyline | OFFSIDES | ||
| 73 | Spironolactone | OFFSIDES | ||
| 74 | Valacyclovir | Canada Vigilance: 1 | Canada Vigilance | |
| 75 | zopiclone | Canada Vigilance: 1 | Canada Vigilance |
Powered by :
Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120240
Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.